Liver Cancer Cell Lines
Database

LCCL to predict drug response

Drug: Navitoclax

DrugsAliasTargetsTargeted cellular functionClinical status in any tumor typeClinical status in HCCSupplierReference
Navitoclax ABT-263 BCL-2 Apoptosis Phase 1, 2 Selleck Chemicals S1001

Cell Line (34)
Cell LineAUCGI50
SNU8780.560.21
HepaRG0.560.089
HCC.1.20.71.555
Li70.70.79
B10.710.825
HCC.30.781.575
SNU3980.788.485
SNU8860.82.525
Hep3B0.814.34
SNU4230.824.44
SNU3540.833.56
SNU4750.845.038
HCC.1.10.864.59
JHH10.886.935
JHH50.884.68


LCCL transcriptomic subgroup:
CL1
CL2
CL3
undef.

Codebase Soc. Coop.
info@codebase.it